308 related articles for article (PubMed ID: 24083675)
1. Omega-3 polyunsaturated fatty acids for major depressive disorder.
Su KP; Wang SM; Pae CU
Expert Opin Investig Drugs; 2013 Dec; 22(12):1519-34. PubMed ID: 24083675
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acids in major depressive disorder.
Freeman MP
J Clin Psychiatry; 2009; 70 Suppl 5():7-11. PubMed ID: 19909687
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
4. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis.
Luo XD; Feng JS; Yang Z; Huang QT; Lin JD; Yang B; Su KP; Pan JY
BMC Psychiatry; 2020 May; 20(1):248. PubMed ID: 32434488
[TBL] [Abstract][Full Text] [Related]
5. Omega 3 polyunsaturated fatty acids and the treatment of depression.
Deacon G; Kettle C; Hayes D; Dennis C; Tucci J
Crit Rev Food Sci Nutr; 2017 Jan; 57(1):212-223. PubMed ID: 25830700
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 polyunsaturated fatty acids and anxiety disorders.
Ross BM
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):309-12. PubMed ID: 19906519
[TBL] [Abstract][Full Text] [Related]
7. Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression.
Su KP
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():151-7. PubMed ID: 18296325
[TBL] [Abstract][Full Text] [Related]
8. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'?
Su KP
Neurosignals; 2009; 17(2):144-52. PubMed ID: 19190401
[TBL] [Abstract][Full Text] [Related]
9. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.
Kalkman HO; Hersberger M; Walitza S; Berger GE
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922396
[TBL] [Abstract][Full Text] [Related]
10. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
[TBL] [Abstract][Full Text] [Related]
11. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments.
Ravindran AV; Lam RW; Filteau MJ; Lespérance F; Kennedy SH; Parikh SV; Patten SB;
J Affect Disord; 2009 Oct; 117 Suppl 1():S54-64. PubMed ID: 19666194
[TBL] [Abstract][Full Text] [Related]
12. Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
Cussotto S; Delgado I; Oriolo G; Kemper J; Begarie D; Dexpert S; Sauvant J; Leboyer M; Aouizerate B; Martin-Santos R; Schaefer M; Capuron L
Depress Anxiety; 2022 May; 39(5):407-418. PubMed ID: 35357051
[TBL] [Abstract][Full Text] [Related]
13. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial.
Rees AM; Austin MP; Parker GB
Aust N Z J Psychiatry; 2008 Mar; 42(3):199-205. PubMed ID: 18247194
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 and omega-6 fatty acid levels in depressive and anxiety disorders.
Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
Psychoneuroendocrinology; 2018 Jan; 87():53-62. PubMed ID: 29040890
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for major depressive disorder.
Connolly KR; Thase ME
Expert Opin Emerg Drugs; 2012 Mar; 17(1):105-26. PubMed ID: 22339643
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic use of omega-3 fatty acids in bipolar disorder.
Balanzá-Martínez V; Fries GR; Colpo GD; Silveira PP; Portella AK; Tabarés-Seisdedos R; Kapczinski F
Expert Rev Neurother; 2011 Jul; 11(7):1029-47. PubMed ID: 21721919
[TBL] [Abstract][Full Text] [Related]
18. The Psychoneuroimmunological Role of Omega-3 Polyunsaturated Fatty Acids in Major Depressive Disorder and Bipolar Disorder.
Rutkofsky IH; Khan AS; Sahito S; Kumar V
Adv Mind Body Med; 2017 Summer; 31(3):8-16. PubMed ID: 28987035
[TBL] [Abstract][Full Text] [Related]
19. Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial.
Rice SM; Hickie IB; Yung AR; Mackinnon A; Berk M; Davey C; Hermens DF; Hetrick SE; Parker AG; Schäfer MR; McGorry PD; Amminger GP
Early Interv Psychiatry; 2016 Aug; 10(4):290-9. PubMed ID: 25130262
[TBL] [Abstract][Full Text] [Related]
20. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index.
Baghai TC; Varallo-Bedarida G; Born C; Häfner S; Schüle C; Eser D; Rupprecht R; Bondy B; von Schacky C
J Clin Psychiatry; 2011 Sep; 72(9):1242-7. PubMed ID: 21208589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
